Peloton Equity
Eric has more than 25 years of experience in the spinal device industry as an entrepreneur, executive, chairman, and board member. Eric co-founded K2M in 2004, a global leader in complex spine and minimally invasive medical device solutions, and led the company to over $280 million in annual revenue, two successful private equity exits (including as an FFC portfolio company), and an IPO in 2014. K2M was acquired by Stryker in 2018 for $1.4 billion, and Eric now serves as president of Stryker’s spine division. Prior to starting K2M, Eric co-founded American OsteoMedix Corporation (AOM) in 1998, a global minimally invasive spine company that was acquired by Interpore Cross (now part of Zimmer Biomet). Eric’s experience also includes numerous sales, marketing, strategy, and product development roles with various medical device companies, including Acromed and Synthes (both now Johnson & Johnson companies).
Eric has also served as a member of the AdvaMed CEO advisory council and sits on the board of directors of the Medical Device Manufacturers Association.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Peloton Equity
1 followers
Peloton Equity is a newly-formed private equity firm that focuses exclusively on growth capital investing in the lower middle market of the healthcare industry. Peloton seeks to invest $15-30MM per company, and has the ability to invest more with co-investments. Peloton is the growth capital investment team spun-out of Ferrer Freeman & Company, which has over 40 years of combined investing experience. Peloton leverages its extensive healthcare network, value-building diligence and investment process, and portfolio management playbook to add value to its portfolio companies.